Ann: Initial Director's Interest Notice, page-4

Not the greatest observation there. I don't think anyone would have expectations of newly appointed managers buying shares.

I'd be more concerned about the churn rate of these managers though. There seems to be a reoccurring story. Oh, the last guy didn't do very well at............. so we now got this guy.

Hopefully this guy can bring more transparency and clarify what's happening with B Braun.

B Braun are still claiming that their Omnitest is using DIABASS and Diasend. Don't see the word 'Bodytel' anywhere. Still raises concerns about when sales from the Bodytel software will actually commence.